Mayland Chang researcher
Chang, Mayland, 1958-
VIAF ID: 60685968 (Personal)
Permalink: http://viaf.org/viaf/60685968
Preferred Forms
- 100 1 _ ‡a Chang, Mayland ‡d 1958-
- 100 1 0 ‡a Chang, Mayland, ‡d 1958-
- 100 0 _ ‡a Mayland Chang ‡c researcher
4xx's: Alternate Name Forms (1)
Works
Title | Sources |
---|---|
Acceleration of diabetic wound healing using a novel protease-anti-protease combination therapy | |
Activities of Oxadiazole Antibacterials against Staphylococcus aureus and Other Gram-Positive Bacteria | |
A chemical biological strategy to facilitate diabetic wound healing. | |
Combined Scaffold Evaluation and Systems-Level Transcriptome-Based Analysis for Accelerated Lead Optimization Reveals Ribosomal Targeting Spirooxindole Cyclopropanes | |
Discovery of a new class of non-β-lactam inhibitors of penicillin-binding proteins with Gram-positive antibacterial activity. | |
Discovery of a potent picolinamide antibacterial active against Clostridioides difficile | |
Discovery of antibiotic (E)-3-(3-carboxyphenyl)-2-(4-cyanostyryl)quinazolin-4(3H)-one | |
Disruption of Allosteric Response as an Unprecedented Mechanism of Resistance to Antibiotics | |
Early Abrogation of Gelatinase Activity Extends the Time Window for tPA Thrombolysis after Embolic Focal Cerebral Ischemia in Mice. | |
Early Gelatinase Activity Is Not a Determinant of Long-Term Recovery after Traumatic Brain Injury in the Immature Mouse | |
Effect of ablation or inhibition of stromal matrix metalloproteinase-9 on lung metastasis in a breast cancer model is dependent on genetic background | |
Endogenous matrix metalloproteinases 2 and 9 regulate activation of CD4+ and CD8+ T cells | |
Exploration of mild copper-mediated coupling of organotrifluoroborates in the synthesis of thiirane-based inhibitors of matrix metalloproteinases | |
Exploration of the Structural Space in 4(3H)-Quinazolinone Antibacterials | |
Generation and exploration of new classes of antitubercular agents: The optimization of oxazolines, oxazoles, thiazolines, thiazoles to imidazo[1,2-a]pyridines and isomeric 5,6-fused scaffolds | |
The haustorium and the chemistry of host recognition in parasitic angiosperms | |
In Search of Selectivity in Inhibition of ADAM10 | |
In Vitro and In Vivo Synergy of the Oxadiazole Class of Antibacterials with β-Lactams | |
Inhibition of human prostate cancer growth, osteolysis and angiogenesis in a bone metastasis model by a novel mechanism-based selective gelatinase inhibitor | |
Inhibition of MMP-9 by a selective gelatinase inhibitor protects neurovasculature from embolic focal cerebral ischemia. | |
Isolation and characterization of semiochemicals involved in host recognition in Striga asiatica | |
Limitations of Knockout Mice and Other Tools in Assessment of the Involvement of Matrix Metalloproteinases in Wound Healing and the Means to Overcome Them | |
MMP-9 inhibitors impair learning in spontaneously hypertensive rats | |
Molecular mechanisms of IL-33-mediated stromal interactions in cancer metastasis | |
Mutations in mmpL and in the cell wall stress stimulon contribute to resistance to oxadiazole antibiotics in methicillin-resistant Staphylococcus aureus | |
The Natural Product Essramycin and Three of Its Isomers Are Devoid of Antibacterial Activity | |
Pharmacological stabilization of intracranial aneurysms in mice: a feasibility study | |
A potent gelatinase inhibitor with anti-tumor-invasive activity and its metabolic disposition | |
The Quinazolinone Allosteric Inhibitor of PBP 2a Synergizes with Piperacillin and Tazobactam against Methicillin-Resistant Staphylococcus aureus | |
Regular and irregular sesquiterpenes containing a halogenated hydropyran from Laurencia caespitosa | |
Restructuring of the extracellular matrix in diabetic wounds and healing: A perspective | |
Role of matrix metalloproteinases and therapeutic benefits of their inhibition in spinal cord injury | |
Roles of matrix metalloproteinases in flow-induced outward vascular remodeling | |
Selective inhibition of matrix metalloproteinase-9 attenuates secondary damage resulting from severe traumatic brain injury | |
Selective Inhibition of MMP-2 Does Not Alter Neurological Recovery after Spinal Cord Injury. | |
Structural Basis for Carbapenemase Activity of the OXA-23 β-Lactamase from Acinetobacter baumannii | |
Structure-Activity Relationship for Thiirane-Based Gelatinase Inhibitors | |
Structure-activity relationship of new anti-tuberculosis agents derived from oxazoline and oxazole benzyl esters | |
Structure of hydroazulenoid diterpenes from a marine alga and their absolute configuration based on circular dichroism | |
Sulfonate-containing thiiranes as selective gelatinase inhibitors | |
Synergistic, collaterally sensitive β-lactam combinations suppress resistance in MRSA. | |
Synthesis and evaluation of 1,2,4-triazolo[1,5-a]pyrimidines as antibacterial agents against Enterococcus faecium | |
Synthesis, kinetic characterization and metabolism of diastereomeric 2-(1-(4-phenoxyphenylsulfonyl)ethyl)thiiranes as potent gelatinase and MT1-MMP inhibitors | |
Synthetic Antimicrobial Peptide Tuning Permits Membrane Disruption and Interpeptide Synergy | |
Targeting Extracellular Matrix Remodeling restores BRAF Inhibitor Sensitivity in BRAFi Resistant Melanoma | |
Testosterone-induced matrix metalloproteinase activation is a checkpoint for neuronal addition to the adult songbird brain | |
The thiirane-based selective MT1-MMP/MMP2 inhibitor ND-322 reduces melanoma tumor growth and delays metastatic dissemination | |
Three-dimensional QSAR analysis and design of new 1,2,4-oxadiazole antibacterials | |
The Tipper-Strominger Hypothesis and Triggering of Allostery in Penicillin-Binding Protein 2a of Methicillin-Resistant Staphylococcus aureus (MRSA). | |
Validation of Matrix Metalloproteinase-9 (MMP-9) as a Novel Target for Treatment of Diabetic Foot Ulcers in Humans and Discovery of a Potent and Selective Small-Molecule MMP-9 Inhibitor That Accelerates Healing | |
Water-soluble mmp-9 inhibitor prodrug generates active metabolites that cross the blood-brain barrier | |
Water-Soluble MMP-9 Inhibitor Reduces Lesion Volume after Severe Traumatic Brain Injury |